Blood test could replace needles for breast cancer monitoring
NCT ID NCT06807502
First seen May 03, 2026 · Last updated May 15, 2026 · Updated 3 times
Summary
This study is testing a new blood test (called a liquid biopsy) to track breast cancer over time. About 93 women with early or advanced breast cancer will give blood samples at several visits. The goal is to see if counting cancer cells in the blood can give doctors useful information without needing a tissue biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CMC Ambroise Paré Hartmann
RECRUITINGNeuilly-sur-Seine, 92200, France
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.